Clinical Laboratory Scientist (CLS) at BillionToOne

Union City, California, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, DiagnosticsIndustries

Requirements

California Clinical Laboratory Scientist License (Required)
Experience in a CLIA-certified laboratory (preferred)
Strong understanding of molecular diagnostics principles
Ability to perform complex laboratory procedures accurately and efficiently
Detail-oriented with excellent organizational skills
Ability to work effectively in a fast-paced environment

Responsibilities

Perform UNITY, the non-invasive prenatal test (NIPT), on maternal blood samples
Ensure accurate and reliable test results
Maintain quality control procedures and adhere to laboratory protocols
Troubleshoot and resolve technical issues related to the UNITY assay
Contribute to process improvement initiatives
Maintain accurate records and documentation
Participate in training and development activities

Skills

California CLS License

Molecular Diagnostics

CLIA Laboratory

NIPT

UNITY Assay

Quality Control

Laboratory Protocols

Troubleshooting

Process Improvement

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$380.2MTotal Funding

SERIES_DCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.

Rapid technological advancements may render their current technology obsolete.

Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.

Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.

They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.

Their new Austin facility will create 1,000 jobs, boosting production and local economy.

Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI

Try Jobo Free